Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer
Title:
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer
Author:
Fetscher, S. Brugger, W. Engelhardt, R. Kanz, L. Hasse, J. Frommhold, H. Wenger, M. Lange, W. Mertelsmann, R.